The news broke through a private channel, not a White House statement. Hunter Biden, speaking on behalf of his father, disclosed that the former president's prostate cancer has advanced—cells now lodged in bone and other organs, pain severe, quality of life degraded. The market didn't blink. No token pump, no protocol dump. But for those of us who audit code for a living, the silence was the signal.
I do not trust the silence, I audit the code.
Healthcare data is the most fragmented, siloed, and opaque system on the planet. A former president's medical chart is guarded by layers of legal and institutional encryption. Yet the underlying disease progression—metastatic castration-resistant prostate cancer (mCRPC)—is a well-documented clinical pathway. The problem is that the data supporting that pathway lives in private databases, PDFs, and physician notes, inaccessible to the very researchers who could advance treatment. This is not a medical problem. It is an infrastructure problem. And infrastructure is what blockchain was built to solve.
Context: The Provenance Gap
Consider the current state of oncology data. A patient's diagnosis, biomarker results (Gleason score, PSA doubling time, HRR mutation status), treatment history (ADT, chemotherapy, novel hormonal therapy, PARP inhibitors), and response metrics are scattered across electronic health records (EHRs) from different vendors, insurance claims databases, and clinical trial registries. No single source of truth exists. When a patient like Biden transitions between care teams—from primary care to urology to medical oncology to palliative care—the data transfer is manual, delayed, and often incomplete. This is not a failure of medicine. It is a failure of coordination.
Blockchain offers a remedy: an immutable, permissioned ledger that records every clinical event, every consent form, every genomic test result, and every treatment outcome as a timestamped, verifiable entry. The patient controls the keys. Researchers get access only through smart contracts that enforce granular consent. No more hunting for PDFs. No more duplicate tests. No more data silos that slow down clinical trials. Truth is an oracle, not a price feed. The oracle of a patient's health should be the patient, mediated by cryptographic proof, not a third-party gatekeeper.
Core: The Technical Architecture of a Healthcare Ledger
Let me be specific. The architecture I would design—and have advised on in private workshops—builds on three layers:
- Identity Layer: A decentralized identifier (DID) for each patient, linked to a verifiable credential (VC) issued by a licensed healthcare provider. This VC contains the patient's basic demographics and consent preferences, signed by the issuer's private key. The patient holds the corresponding private key, enabling selective disclosure.
- Data Layer: Clinical events (diagnosis, lab results, medication administrations, imaging reports) are hashed and anchored to a permissioned blockchain (e.g., Hyperledger Fabric or a sidechain to Ethereum) with access control lists encoded in smart contracts. The raw data remains off-chain in encrypted storage (IPFS with encryption or a private cloud), but the hash and metadata are on-chain. Any alteration to the off-chain data would break the hash link, providing tamper evidence.
- Consent Layer: Smart contracts manage consent revocation and data sharing. For example, a researcher can request access to a cohort of patients with mCRPC and bone metastases. The smart contract checks each patient's consent status (granted via a signed VC) and, if approved, provides a one-time decryption key for the relevant data. The entire audit trail is recorded on-chain.
Why this matters for Biden's case: If his treatment history, genomic profile, and progression data were stored on such a ledger, the global oncology community could instantly analyze the effectiveness of his specific regimen—without exposing his identity. The data would be pseudonymous, but the statistical power of a single real-world case following a known clinical path is enormous. Proof precedes value; provenance is the only art.
Contrarian: The Pragmatic Collapse
Now, let me be the one to call out the elephant in the room. Blockchain is not a panacea. The healthcare industry is notoriously slow to adopt new technology, and for good reason: regulatory compliance (HIPAA, GDPR), liability concerns, and the sheer inertia of legacy systems. A permissioned blockchain still requires a trusted consortium of hospitals, insurers, and regulators to run the nodes. Who controls the governance? Who decides what data gets written? Who pays for the infrastructure? These are not technical questions; they are political and economic ones.
Moreover, the privacy promises of blockchain are often overstated. Even with encryption, metadata analysis can reveal patterns. A patient's diagnosis timestamp combined with their age and location could be re-identified. Zero-knowledge proofs and secure multi-party computation can mitigate this, but they add computational overhead and complexity. The average oncologist doesn't want to manage cryptographic keys. The average patient doesn't understand consent smart contracts. Fragility hides in the single point of failure. In this case, the single point is the human interface.
But the contrarian view also reveals the opportunity. The very reason large institutions resist blockchain—the loss of control over data—is precisely why it is necessary. The current system is fragile because it relies on centralized trust. A single ransomware attack on a hospital network can paralyze care. A single data broker can sell patient records without consent. Blockchain, even with its flaws, shifts the trust model from institutions to mathematics. That is a structural improvement, not a perfect one.
Takeaway: The Vision Forward
The Biden story is a reminder that healthcare data is the most valuable asset we collectively own—and the most poorly managed. The blockchain community has spent years building infrastructure for financial assets. It is time to apply the same rigor to health. The tools are ready: DID, verifiable credentials, zk-proofs, and permissioned ledgers. What is missing is the will to bridge the gap between the cryptographic and the clinical.
We do not buy pixels, we buy history. The history of a cancer patient's journey is the most valuable dataset for future generations. It should be recorded on an immutable ledger, not in a filing cabinet. Let this be the moment we stop treating health data as a liability and start treating it as an asset—one that belongs to the patient, secured by code, and available for research under their control.
Code is law, but audits are conscience. The audit of our healthcare system shows a metastasizing fragmentation. Blockchain is the therapy. The question is whether we have the courage to prescribe it.